STACEY WARING: Open Payments
NPI 1124174198 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 29 payments from 13 companies in 2025. Trend: 2023 $916 · 2024 $911 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $226 |
| Novo Nordisk Inc | 6 | $111 |
| Averitas Pharma Inc. | 1 | $40 |
| PFIZER INC. | 2 | $33 |
| Neuronetics, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: UBRELVY, Wegovy, QUTENZA, NEUROSTAR TMS THERAPY SYSTEM, GEMTESA, MOUNJARO, VRAYLAR, ELIQUIS.
Industry payments across KY — which companies pay providers there.
